8-Bromo-3-iodoimidazo[1,2-a]pyridine, 97%, 250mg

3',4'-dihydro-2'H-spiro[cyclopentane-1,1'-pyrrolo[1,2-a]pyrazine], 95.0%, 25g

3-Trifluoromethylphenylthioethanol, 98.0%, 1g

2-Bromo-3-methoxy-5-(trifluoromethyl)pyridine, 98%, 250mg

N-((1S,2S)-2-Amino-1,2-diphenylethyl)methanesulfonamide, 97%, 100mg

Etile cloroacetato, >=98%, per sintesi, 2,5 L, confezione in vetro

Soluzione di acido borico 4%, pa, 1 l, confezione di plastica.

2-(4,5-Difluoro-2-nitrophenyl)acetonitrile, 95+%, 1g

1,3-Dibromo-5-dodecylbenzene, 97% GC, 1g

N-Acetyl-L-histidine Monohydrate, 97.00%, 1g

Methyl 5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazole-4-carboxylate, 98%, 100mg

Diethylamino-phenyl-acetic acid, 95.0%, 1g

5-Phenyl-1,3-oxazole, 95.0%, 1g